Literature DB >> 23124364

Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports.

Tsung-Ting Hsieh1, Hsiang-Kuang Tseng, Pei-Lun Sun, Yu-Hung Wu, Gon-Shen Chen.   

Abstract

Cunninghamella bertholletiae is an unusual opportunistic pathogen belonging to the class Zygomycetes, order Mucorales, and the family Cunninghamellaceae. It has been identified with increased frequency in immunocompromised patients, especially those with hematological malignancy. Clinical infection by this fungus is almost always devastating. We report a fatal case of disseminated zygomycosis due to Cunninghamella bertholletiae in an acute myeloid leukemia patient without chemotherapy. We also reviewed the cases of Cunninghamella bertholletiae infection reported in these 20 years. These cases highlight the high mortality rate and rapid progression associated with this opportunistic fungal infection in immunocompromised patients.

Entities:  

Mesh:

Year:  2012        PMID: 23124364     DOI: 10.1007/s11046-012-9595-y

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  42 in total

1.  [Pulmonary mucormycosis caused by Cunninghamella bertholletiae in a non-immunocompromised woman].

Authors:  M Sato; H Gemma; T Sano; T Ono; E Atsumi; I Ito; K Chida; H Nakamura
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2001-10

2.  Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature.

Authors:  Jorge Garbino; Catherine Myers; Juan Ambrosioni; Fabienne Gumy-Pause
Journal:  J Pediatr Hematol Oncol       Date:  2010-03       Impact factor: 1.289

3.  Nosocomial invasive infection caused by Cunninghamella bertholletiae: case report.

Authors:  Xisto Sena Passos; Werther Souza Sales; Patrícia Jackeline Maciel; Carolina Rodrigues Costa; Denise Milioli Ferreira; Maria Rosário Rodrigues do Silva
Journal:  Mycopathologia       Date:  2006-01       Impact factor: 2.574

4.  Peritonitis due to Cunninghamella bertholletiae in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  Jason D Pimentel; Gavin Dreyer; Gary D Lum
Journal:  J Med Microbiol       Date:  2006-01       Impact factor: 2.472

5.  Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.

Authors:  Susanne Perkhofer; Maria Locher; Manuel Cuenca-Estrella; Reinhard Rüchel; Reinhard Würzner; Manfred P Dierich; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

6.  Spectrum of zygomycete species identified in clinically significant specimens in the United States.

Authors:  E Alvarez; D A Sutton; J Cano; A W Fothergill; A Stchigel; M G Rinaldi; J Guarro
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

Review 7.  Treatment of zygomycosis: current and new options.

Authors:  Thomas R Rogers
Journal:  J Antimicrob Chemother       Date:  2008-01       Impact factor: 5.790

8.  Survival of a patient with pulmonary Cunninghamella bertholletiae infection without surgical intervention.

Authors:  Nobuyuki Koyama; Makoto Nagata; Koichi Hagiwara; Minoru Kanazawa
Journal:  Respirology       Date:  2008-03       Impact factor: 6.424

9.  Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient.

Authors:  D Quinio; A Karam; J P Leroy; M C Moal; B Bourbigot; O Masure; B Sassolas; A M Le Flohic
Journal:  Med Mycol       Date:  2004-04       Impact factor: 4.076

10.  Native aortic valve vegetative endocarditis with Cunninghamella.

Authors:  Nehal Nikhilesh Mehta; Jeanine Romanelli; Martin Graham St John Sutton
Journal:  Eur J Echocardiogr       Date:  2004-03
View more
  5 in total

1.  Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.

Authors:  Guanpingsheng Luo; Teclegiorgis Gebremariam; Hongkyu Lee; Samuel W French; Nathan P Wiederhold; Thomas F Patterson; Scott G Filler; Ashraf S Ibrahim
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

2.  Disseminated Cunninghamella bertholletiae mucormycosis with protracted clinical course and formation of a large intra-ventricular mural thrombus.

Authors:  Masayuki Shintaku; Eiji Yamada; Makoto Ohta; Kohei Yoshikawa
Journal:  Int J Clin Exp Pathol       Date:  2022-05-15

3.  Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.

Authors:  Hikari Ota; Hisashi Yamamoto; Muneyoshi Kimura; Hideki Araoka; Takeshi Fujii; Takashi Umeyama; Hideaki Ohno; Yoshitsugu Miyazaki; Daisuke Kaji; Yuki Taya; Aya Nishida; Kazuya Ishiwata; Masanori Tsuji; Shinsuke Takagi; Yuki Asano-Mori; Go Yamamoto; Naoyuki Uchida; Koji Izutsu; Kazuhiro Masuoka; Atsushi Wake; Akiko Yoneyama; Shigeyoshi Makino; Shuichi Taniguchi
Journal:  Mycopathologia       Date:  2017-06-02       Impact factor: 2.574

4.  Disseminated mycosis in a patient with yellow fever.

Authors:  Gustavo Vieira Rodrigues Maciel; Marcelo Combat de Faria Tavares; Leonardo Soares Pereira; Guilherme Lima Castro Silva; Neimy Ramos de Oliveira; Eduardo Paulino; Marcelo Antonio Pascoal-Xavier
Journal:  Autops Case Rep       Date:  2018-08-13

Review 5.  Global Cutaneous Mucormycosis: A Systematic Review.

Authors:  Anna Skiada; Maria Drogari-Apiranthitou; Ioannis Pavleas; Eirini Daikou; George Petrikkos
Journal:  J Fungi (Basel)       Date:  2022-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.